Last reviewed · How we verify
NCT05374863
Intradialytic Physiotherapy in Patients With Chronic Kidney Disease
NA trial testing Neuromuscular electrical stimulation (NMES) - Active in Chronic Renal Diseases in 30 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Marcela Cangussu Barbalho |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 August 2022 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Neuromuscular electrical stimulation (NMES) - Active
- Neuromuscular Electrical Stimulation (NMES) - Sham
- Aerobic exercise with cycle ergometer
Conditions studied
- Chronic Renal Diseases — all drugs for Chronic Renal Diseases →
Sponsor
Marcela Cangussu Barbalho
Who can join
18 and older, any sex, with Chronic Renal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective is to evaluate in adult patients with chronic kidney disease the effect of neuromuscular electrical stimulation (NMES) in the upper limbs associated with a cycle ergometer in the lower limbs, during hemodialysis, on functional capacity and peripheral muscle strength. The hypothesis is that in people with chronic kidney disease on hemodialysis, the addition of neuromuscular electrical stimulation in the upper limbs associated with aerobic training of the lower limbs is superior to aerobic exercise alone in improving functional capacity, peripheral muscle strength, quality of life, safety intervention and patient adherence.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and Feasibility of Intradialytic Exercise Including Upper Limb Neuromuscular Electrical Stimulation in Adults With Chronic Kidney Disease: A Randomized Controlled Pilot Clinical Trial.
Rosa MR, de Souza VS, Paro FM, Gomes DCAP, et al · · 2025 · PMID 40799154 · DOI 10.1111/aor.70006
Verify or expand the search:
- PubMed search for NCT05374863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Renal Diseases
Currently open trials in the same condition.
- NCT06688994 — Vitamin D Metabolites as Biomarkers for the Identification of Kidney Injury in Cardiac Surgery · active not recruiting
- NCT04334707 — Kidney Precision Medicine Project · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05374863 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marcela Cangussu Barbalho
- Last refreshed: 21 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05374863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing